Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina

Epidemiology and Infection

Volumn 141, Issue 4, 2013, Pages 718-734

  Fabricius, G ^a   Bergero, P E ^a   Ormazabal, M E ^b   Maltz, A L ^c   Hozbor, D F ^b  

^a INSTITUTO DE INVESTIGACIONES FISICOQUÍMICAS TEÓRICAS Y APLICADAS INIFTA   (Argentina)

^b FACULTAD DE CIENCIAS EXACTAS   (Argentina)

^c UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

Author keywords

Epidemic; mathematical model; pertussis; Tdap booster

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT HEALTH; AGE DISTRIBUTION; ARGENTINA; ARTICLE; COMPARTMENT MODEL; DISEASE TRANSMISSION; DRUG EFFICACY; IMMUNIZATION; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; INCIDENCE; MATHEMATICAL COMPUTING; PERTUSSIS; RISK REDUCTION; STATISTICAL MODEL;

ADOLESCENT; ARGENTINA; CHILD; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; INFANT; MODELS, THEORETICAL; PERTUSSIS VACCINE; WHOOPING COUGH;

EID: 84874496245     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812001380     Document Type: Article

References (42)

1. Anon. Pertussis - United States, 1997-2000. Morbidity and Mortality Weekly Report 2002; 51: 73-76
2. WHO. Pertussis vaccines: WHO position paper. Weekly Epidemiological Record 2010; 85: 385-400
3. Baron S, et al. Epidemiology of pertussis in French hospitals in 1993 and 1994: Thirty years after a routine use of vaccination. Pediatric Infectious Disease Journal 1998; 17: 412-418
4. de Melker HE, et al. Pertussis in The Netherlands: An outbreak despite high levels of immunization with whole-cell vaccine. Emerging Infectious Diseases 1997; 3: 175-178
5. Hozbor D, et al. Pertussis epidemiology in Argentina: Trends over 2004-2007. Journal of Infection 2009; 59: 225-231
6. de Melker HE, et al. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. Journal of Infection 2006; 53: 106-113
7. Mooi FR. Bordetella pertussis and vaccination: The persistence of a genetically monomorphic pathogen. Infection, Genetics and Evolution 2010; 10: 36-49
8. Kallonen T, He Q. Bordetella pertussis strain variation and evolution postvaccination. Expert Review of Vaccines 2009; 8: 863-875
9. Wendelboe AM, et al. Duration of immunity against pertussis after natural infection or vaccination. Pediatric Infectious Disease Journal 2005; 24: S58-61
10. Yih WK, et al. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. Journal of Infectious Disease 2000; 182: 1409-1416
11. Forsyth KD, et al. Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 2007; 25: 2634-2642
12. CDC. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months - Advisory Committee on Immunization Practices (ACIP), 2011. Morbidity and Mortality Weekly Reports 2011; 60: 1424-1426
13. Anderson RM, May RM. Age-related changes in the rate of disease transmission: Implications for the design of vaccination programmes. Journal of Hygiene 1985; 94: 365-436
14. Grenfell BT, Anderson RM. Pertussis in England and Wales: An investigation of transmission dynamics and control by mass vaccination. Proceedings of the Royal Society of London, Series B 1989; 236: 213-252
15. Hethcote HW. An age-structured model for pertussis transmission. Mathematical Biosciences 1997; 145: 89-136
16. van Boven M, et al. Waning immunity and sub-clinical infection in an epidemic model: Implications for pertussis in The Netherlands. Mathematical Biosciences 2000; 164: 161-182
17. Luz PM, et al. A modelling analysis of pertussis transmission and vaccination in Rio de Janeiro, Brazil. Epidemiology and Infection 2006; 134: 850-862
18. Wearing HJ, Rohani P. Estimating the duration of pertussis immunity using epidemiological signatures. PLoS Pathogens 2009; 5: E1000647
19. Lavine JS, King AA, Bjornstad ON. Natural immune boosting in pertussis dynamics and the potential for long-Term vaccine failure. Proceedings of the National Academy of Sciences USA 2011; 108: 7259-7264
20. Rohani P, Zhong X, King AA. Contact network structure explains the changing epidemiology of pertussis. Science 2010; 330: 982-985
21. Forsyth KD, et al. Pertussis immunization in the Global Pertussis Initiative International Region Recommended Strategies and Implementation Considerations. Pediatric Infectious Disease Journal 2005; 24: S93-S97
22. Argentinean Health Ministry database. (http://msal. gov.ar/htm/site/pdf/ epidemiologia/boletin-semanal/ BoletinIntegradoDeVigilanciaVersionVF-SE34.pdf). Accessed 10 May 2012
23. Argentinean Health Ministry database. (http://msal.gov. ar/htm/site/pdf/AnexoVII-PAI-03-09.pdf). Accessed 10 May 2012
24. Riva Posse CA, Miceli IN. Pertussis: Its evolution in Argentina at the end of the twentieth century. Medicina (Buenos Aires) 2005; 65: 7-16
25. Anderson R, May R. Infectious Diseases of Humans: Dynamics and Control. Oxford: Oxford University Press, 1991
26. Broutin H, et al. Large-scale comparative analysis of pertussis population dynamics: Periodicity, synchrony, and impact of vaccination. American Journal of Epidemiology 2005; 161: 1159-1167
27. Broutin H, et al. Impact of vaccination and birth rate on the epidemiology of pertussis: A comparative study in 64 countries. Proceedings of the Royal Society of London, Series B, 2010; 277: 3239-3245
28. Van Rie A, Hethcote HW. Adolescent and adult pertussis vaccination: Computer simulations of five new strategies. Vaccine 2004; 22: 3154-3165
29. Rozenbaum MH, et al. Modelling the impact of extended vaccination strategies on the epidemiology of pertussis. Epidemiology and Infection. Published online: 24 November 2011. doi:10.1017/S0950268811002354
30. Kretzschmar M, Teunis PF, Pebody RG. Incidence and reproduction numbers of pertussis: Estimates from serological and social contact data in five European countries. PLoS Medicine 2010; 7: E1000291
31. Mossong J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Medicine 2008; 5: E74
32. Hethcote HW. Simulations of pertussis epidemiology in the United States: Effects of adult booster vaccinations. Mathematical Biosciences 1999; 158: 47-73
33. Rohani P, Earn D, Grenfell BT. Opposite patterns of synchrony in sympatric disease metapopulations. Science 1999; 286: 968
34. Simoes M, Telo da Gama MM, Nunes A. Stochastic fluctuations in epidemics on networks. Journal of the Royal Society Interface 2008; 5: 555-566
35. Gonç alves S, Abramson G, Gomes MFC. Oscillations in SIRS model with distributed delays. European Physical Journal B 2011; 81: 363-371
36. Brooks DA, Clover R. Pertussis infection in the United States: Role for vaccination of adolescents and adults. Journal of the American Board of Family Medicine 2006; 19: 603-611
37. Quinn HE, McIntyre PB. The impact of adolescent pertussis immunization, 2004-2009: Lessons from Australia. Bulletin of the World Health Organization 2011; 89: 666-674
38. Skoff TH, et al. Early Impact of the US Tdap vaccination program on pertussis trends. Archives of Pediatrics and Adolescent Medicine 2012; 166: 344-349
39. Jardine A, et al. Who gives pertussis to infants ? Source of infection for laboratory confirmed cases less than 12 months of age during an epidemic, Sydney, 2009. Communicable Diseases Intelligence 2010; 34: 116-121
40. Bisgard KM, et al. Infant pertussis: Who was the source ? Pediatric Infectious Disease Journal 2004; 23: 985-989
41. Wendelboe AM, et al. Transmission of Bordetella pertussis to young infants. Pediatric Infectious Disease Journal 2007; 26: 293-299
42. Lavine JS, et al. Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine. Vaccine 2012; 30: 544-551